NuLife Sciences, Inc. Stock: price and insider trades · United States
NuLife Sciences, Inc.: what insiders have been doing
Every trade that managers of NuLife Sciences, Inc. disclose to SEC (Form 4) is tracked on this page. No insider at NuLife Sciences, Inc. has published a filing in the past twelve months. The most recent one dates from 18 July 2017.
Our records for NuLife Sciences, Inc. go back to 2017, with no purchases and 2 sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
- 55,000 shares@ US$0.25100.0% of flowSeries A Preferred StockSEC:0001391609-17-000183:0
- 100,000 shares@ US$0.0112.5% of flowCommon stockSEC:0001391609-17-000171:0
- 700,000 shares@ US$0.0187.5% of flowCommon stockSEC:0001391609-17-000171:2
3 of 3 declarations
About NuLife Sciences, Inc.
NuLife Sciences, Inc. is a company listed on the XNAS market, specializing in the development of innovative solutions for the healthcare sector. It focuses on the research and commercialization of products related to life sciences.
